Literature DB >> 11860085

Chiral inversion of (R)-ketoprofen: influence of age and differing physiological status in dairy cattle.

L Igarza1, A Soraci, N Auza, H Zeballos.   

Abstract

The chiral inversion of ketoprofen has been previously demonstrated in cattle, but no studies have been performed on different ages and metabolic situations in the animals. The aim of this work was to study any modifications of the stereoconversion of ketoprofen that occur by reason of age, lactation or gestation in dairy cows. Holando Argentino cattle were divided into three groups: 8 cows in early lactation, 8 pregnant cows and 8 newborn calves. Four animals from each group received the enantiomer R-(-)-ketoprofen by intravenous administration; the other four animals received the S-(+) enantiomer, all at doses of 0.5 mg/kg. Blood samples were collected at standardized times after dosing and assayed for ketoprofen by high-performance reversed-phase liquid chromatography (HPLC). The percentage inversion of R-(-)-ketoprofen to S-(+)-ketoprofen was 50.5% (SD +/- 2.4) in the preruminants, 33.3% (SD +/- 1.7) in cows in early lactation and 26.0% (SD +/- 5.1) in cows in gestation. These results indicate a differing enantioselective metabolic behaviour for one compound in one species under different physiological situations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11860085     DOI: 10.1023/a:1013301620904

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  36 in total

Review 1.  Preclinical and clinical development of dexketoprofen.

Authors:  D Mauleón; R Artigas; M L García; G Carganico
Journal:  Drugs       Date:  1996       Impact factor: 9.546

2.  High-performance liquid chromatographic assay of ketoprofen enantiomers in human plasma and urine.

Authors:  R T Foster; F Jamali
Journal:  J Chromatogr       Date:  1987-05-15

Review 3.  Etiology of lipid-related metabolic disorders in periparturient dairy cows.

Authors:  R R Grummer
Journal:  J Dairy Sci       Date:  1993-12       Impact factor: 4.034

Review 4.  Interrelationships between xenobiotic metabolism and lipid biosynthesis.

Authors:  J Caldwell; M V Marsh
Journal:  Biochem Pharmacol       Date:  1983-06-01       Impact factor: 5.858

Review 5.  Interactions of anti-inflammatory 2-arylpropionates (profens) with the metabolism of fatty acids: in vitro studies.

Authors:  J M Mayer; M Roy-De Vos; C Audergon; B Testa; J C Etter
Journal:  Int J Tissue React       Date:  1994

6.  Pharmacokinetic analysis of the enantiomeric inversion of chiral nonsteroidal antiinflammatory drugs.

Authors:  R Mehvar; F Jamali
Journal:  Pharm Res       Date:  1988-02       Impact factor: 4.200

7.  Chiral inversion of fenoprofen in horses and dogs: an in vivo-in vitro study.

Authors:  A Soraci; P Jaussaud; E Benoit; P Delatour
Journal:  Vet Res       Date:  1996       Impact factor: 3.683

Review 8.  The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences.

Authors:  J Caldwell; A J Hutt; S Fournel-Gigleux
Journal:  Biochem Pharmacol       Date:  1988-01-01       Impact factor: 5.858

9.  Acyl-CoA synthetase mRNA expression is controlled by fibric-acid derivatives, feeding and liver proliferation.

Authors:  K Schoonjans; B Staels; P Grimaldi; J Auwerx
Journal:  Eur J Biochem       Date:  1993-09-01

10.  In vitro fenoprofenyl-coenzyme A thioester formation: interspecies variations.

Authors:  A Soraci; E Benoit
Journal:  Chirality       Date:  1995       Impact factor: 2.437

View more
  2 in total

1.  A pharmacokinetic comparison of meloxicam and ketoprofen following oral administration to healthy dogs.

Authors:  L Montoya; L Ambros; V Kreil; R Bonafine; G Albarellos; R Hallu; A Soraci
Journal:  Vet Res Commun       Date:  2004-07       Impact factor: 2.459

2.  Some pharmacokinetic parameters of R-(-)- and S-(+)-ketoprofen: the influence of age and differing physiological status in dairy cattle.

Authors:  L Igarza; A Soraci; N Auza; H Zeballos
Journal:  Vet Res Commun       Date:  2004-01       Impact factor: 2.459

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.